
Device Survival Probability
VEDR01_SURV
1 yr | 2 yr | 3 yr | 4 yr | 5 yr | 6 yr | 7 yr | 8 yr | 9 yr | 10 yr | 11 yr | 12 yr | 13 yr | 14 yr | at 170.0 mo | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% | ![]() |
100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | ||||||
% | ![]() |
100.0 | 99.9 | 99.8 | 99.6 | 99.2 | 98.6 | 97.1 | 92.2 | 80.1 | 64.9 | 51.2 | 40.2 | 33.5 | 29.7 | 28.9 | ||||||
# | 98697 | 90201 | 82109 | 74730 | 67698 | 60386 | 52144 | 43029 | 31141 | 20111 | 11776 | 6085 | 2644 | 418 | 110 |
- Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
- Excluding Normal Battery Depletion – This is the malfunction free survival curve.

Product Characteristics
Generator Type | IPG |
---|---|
NBD Code | DDDR |
Max. Delivered Energy | N/A |
Connector Style | IS-1 UNI/BI |
---|---|
Serial Number Prefix | NWH, PWH |
Mass | 27.1 g |
Volume | 12.1 cc |
Waveform | N/A |
X-Ray ID | PWH, PWB |

Estimated Longevity
Amplitude Setting | 500 Lead Ω | 1000 Lead Ω |
---|---|---|
Low 2.5 V (A, RV) | 7.4 | 9.1* | 8.2 | 10.3* |
Nominal 3.5 V (A, RV) | 6.0 | 7.2* | 7.4 | 9.0* |
High 5.0 V (A, RV) | 4.5 | 5.1* | 6.0 | 7.0* |
*The second longevity numbers provided apply to the N-series Versa VEDR01 product. The N-series products have increased longevity because of improved electronic circuitry. Click on "Other Articles" for more information on the N-series longevity. Longevity estimates based on the following device usage. Pace/Sense Mode DDD ; Atrial Pulse Width 0.4 ms; Right Ventricle Pulse Width 0.4 ms; Lower Pace Rate 60 bpm; Right Ventricle Percent Paced 100 %; EGM Prestorage ON ; Upper Sensing Rate 130 ppm; Atrial Percent Paced 100 %; EGM Prestorage ON Time 1 ; Atrial Fib Percent of Time 0 %Hide this content

Distribution Data
US Market Release | 2006-07-17 |
---|---|
CE Approval Date | 2005-09-20 |
Registered USA Implants | 118951 |
Estimated Active USA Implants | 26783 |
Normal Battery Depletions | 13214 |
US Market Release | 2006-07-17 |
---|---|
CE Approval Date | 2005-09-20 |
Estimated WW Distribution | 178054 |
Normal Battery Depletions | 13243 |

EOS Indication
Prolonged Service period is 3 months after RRT/ERI assuming 100% pacing at the listed parameter settings. Reprogramming of pacing parameters may reduce the duration of the prolonged service period.
Data as of May 10, 2023